We are live on ! Find out more
NDRA icon

ENDRA Life Sciences

8 hedge funds and large institutions have $1.86M invested in ENDRA Life Sciences in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more funds holding

Funds holding: 38 (+5)

101% more capital invested

Capital invested by funds: $924K → $1.86M (+$936K)

0% more ownership

Funds ownership: 0%0% (+0%)

Holders
8
Holders Change
+5
Holders Change %
+166.67%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
1
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

NDRA Hedge Fund Activity: Q4 2018 in Review

8 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q4 2018, worth a combined $1.86M — up 101% from $924K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new NDRA positions and 0 closed out — a net gain of 5 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was ICM Asset Management, adding an estimated $1.74M. The largest seller was Jane Street, cutting an estimated $36K.

  • 8 institutional investors held ENDRA Life Sciences (NDRA) as of Q4 2018, up from 3 in Q3 2018.
  • Funds reported $1.86M of ENDRA Life Sciences stock for Q4 2018, up 101% quarter-over-quarter.
  • 5 funds opened new ENDRA Life Sciences positions in Q4 2018 and 0 closed out, a net change of +5 holders.
  • The largest ENDRA Life Sciences buyer in Q4 2018 was ICM Asset Management, an estimated $1.74M added.
  • The largest ENDRA Life Sciences seller in Q4 2018 was Jane Street, an estimated $36K sold.

Based on aggregated 13F filings for Q4 2018.